The New Era in Alzheimer's Diagnosis and Treatment
John C. Morris, M.D.
Friedman Distinguished Professor of Neurology
Director, Knight Alzheimer Disease Research Center
Washington University School of Medicine
Maury Strauss Distinguished Public Lecture
The New Era in Alzheimer's Diagnosis and Treatment
Date: May 14, 2026
Time: 5:30 - 6:30 p.m. (Reception and hors d'oeuvres at 5 p.m.)
In-person: Room M203, 2 Riverside Circle, Fralin Biomedical Research Institute at VTC
Virtual: Join via Zoom or live webcast
About this Seminar
Since 2023, anti-amyloid immunotherapies have been approved by the United States Food and Drug Administration for the treatment of persons with very mild to mild symptomatic Alzheimer's disease (AD). These amyloid-targeting treatments (ATTs) do not cure AD, but can slow the rate of cognitive and functional decline, thus prolonging the period in which the patient retains independence. However, benefit is optimal when AD is accurately diagnosed early in its symptomatic course. Early diagnosis has now been notably facilitated by the availability of accurate, acceptable, and accessible blood-based biomarker (BBM) tests for AD. Together, BBMs and ATTs usher in a new era in AD diagnosis and treatment.
Additional Details
This is a free event hosted by Dr. Michael Friedlander and the Fralin Biomedical Research Institute. For more information, please call 540-526-2059.
About Maury Strauss
Maury Strauss was a longtime community benefactor and businessman who supported biomedical research with the goal of energizing the local economy and improving quality of life in our neighborhoods and around the world. In order to ensure the continued success of Roanoke’s biomedical research enterprise, as well as the free public seminars, Mr. Strauss made a generous gift to the series. He passed away in June 2024 at age 99.
Support Our Research
Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.
You May Also Be Interested In...
-
Home Item
Understanding Vascular Morphogenesis and Morphology: Live Insights from Zebrafish , homeNov. 21, 2025, 11:00 a.m. | Arndt F. Siekmann, Ph.D., Associate Professor, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute
-
Home Item
The Metabolic Switch in Development and Degeneration , homeDec. 12, 2025, 11:00 a.m. | Elizabeth Jonas, M.D., Harvey and Kate Cushing Professor of Internal Medicine (Endocrinology), Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
Innovative Strategies for Overcoming Challenges in Brain Tumor Treatment , homeJan. 16, 2026, 11:00 a.m. | Kristin Huntoon, Ph.D., D.O., Assistant Professor, Department of Neurosurgery, University of Arizona | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Maury Strauss Distinguished Public Lecture , homeJan. 22, 2026, 5:30 p.m. (Reception at 5 p.m.) | Holly Ingraham, Ph.D., Professor, Cellular and Molecular Pharmacology; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
Policies to Reduce Ultra-processed Foods: Lessons From Around the Globe , homeJan. 30, 2026, 11:00 a.m. | Lindsey Smith Taillie, Ph.D., MPH, Associate Professor of Nutrition, Associate Chair of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home Item
AI and Agentic AI: Opportunities for How We Work, Care, Discover, and Share , homeFeb. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Vivian S. Lee, M.D., Ph.D., M.B.A., Executive Fellow, Harvard Business School; Senior Lecturer, Harvard Medical School; Elected Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture